Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Aminohexylgeldanamycin (AHGDM), a derivative of Geldanamycin, is a highly effective inhibitor of HSP90. It exhibits considerable antiangiogenic and antitumor properties[1].
パッケージサイズ | 在庫状況 | 単価(税別) |
---|---|---|
25 mg | 約6-8 週間 | ¥ 211,500 |
50 mg | 約6-8 週間 | ¥ 271,000 |
100 mg | 約6-8 週間 | ¥ 411,000 |
説明 | Aminohexylgeldanamycin (AHGDM), a derivative of Geldanamycin, is a highly effective inhibitor of HSP90. It exhibits considerable antiangiogenic and antitumor properties[1]. |
In vitro | HPMA copolymer-aminohexylgeldanamycin conjugates are designed to target the GRP78 protein, which is expressed on the surface of prostate cancer cells[2]. |
分子量 | 644.8 |
分子式 | C34H52N4O8 |
CAS No. | 485395-71-9 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 200 mg/mL (310.17 mM)
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Aminohexylgeldanamycin 485395-71-9 Inhibitor inhibitor inhibit